(2-Formyl-3-methoxyphenyl)boronic acid, 98.0%, 250mg

Pentaeritritol, mínimo 98%, para síntesis, 100 g, envase de plástico.

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96.0%, 50g

Olanzapine>98.0%(GC)(T)1g

3-Fluoro-5-nitropyridin-2-ol, 95.0%, 10g

(2,5-Dimethoxyphenyl)methanol, 95.0%, 1g

Butyl 4-aminobenzoate, 95.0%, 5g

(R)-Oxetan-2-ylmethanamine, 98%, 5g

1-(Chloromethyl)-3,5-difluorobenzene, 98.0%, 100g

tert-Butyl 4-(trifluoromethyl)piperazine-1-carboxylate, 98%, 50mg

2-[2-(Methoxymethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

Methyl 2-trifluoromethylbenzoylacetate, 98.0%, 1g

Fmoc-(S)-2-amino-4-(2-pyridyl)butyric acid, 98%, 250mg